246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid
The Readout Loud
00:00
Biogen Earnings - Is Chris Veebaker Boring?
Biogen's earnings call was the first opportunity for investors to hear new CEO Chris Veebaker speak. The company guided down earnings and revenue for the coming year, but that was expected. Stelios Papadopoulos, the longtime chairman is resigning from the worst stepping back from the board.
Transcript
Play full episode
